Charles Rochester Blood Clot Prevention and Treatment Act
This bill directs the CDC to launch public education campaigns about blood clot risks, symptoms, and prevention, with special focus on high-risk groups including Black Americans, cancer patients, seniors, and hospitalized individuals. It creates a new 18-month advisory committee to study DVT/PE data collection, develop prevention guidelines, and recommend improved care standards for at-risk patients. The bill also mandates a federal study on electronic health record systems for better DVT/PE surveillance and authorizes $20 million annually for these efforts through fiscal year 2029. These provisions aim to reduce preventable deaths and improve early diagnosis, directly affecting millions at risk of blood clots nationwide.
Bill status
in committee
1 of 4 stages cleared
Introduction
Sep 2023
Committee Review
Floor Vote
President
Introduced Sep 26, 2023
Last action Sep 29, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Sep 29, 2023
Committee
Referred to the Subcommittee on Health.
lower
Sep 26, 2023
Committee
Referred to the House Committee on Energy and Commerce.
lower
Sep 26, 2023
Introduced
Introduced in House
lower
1 primary · 29 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Lisa Blunt Rochester
DDemocratic
Co
Barbara Lee
DDemocratic
Co
Bill Pascrell, Jr.
DDemocratic
Co
Brian K. Fitzpatrick
RRepublican
Co
Darren Soto
DDemocratic
Co
Debbie Dingell
DDemocratic
Co
Donald G. Davis
DDemocratic
Co
Dwight Evans
DDemocratic
Co
Eleanor Holmes Norton
DDemocratic
Co
J. Luis Correa
DDemocratic
Co
Jake LaTurner
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 5699
Scope: US
Hi! I can help you understand HR 5699. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline